ISRG - Intuitive Surgical - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US46120E6023

Surgical Systems, Diagnostic Systems, Medical Instruments, Support Services

Intuitive Surgical, Inc. is a pioneer in the field of medical technology, dedicated to improving the quality and accessibility of minimally invasive care globally.

The company's flagship product, the da Vinci Surgical System, revolutionizes complex surgeries by enabling physicians to perform procedures with enhanced precision and control, reducing trauma to patients and promoting faster recovery times.

Building on its surgical expertise, Intuitive Surgical has expanded its product portfolio to include the Ion endoluminal system, a groundbreaking diagnostic tool that enables minimally invasive biopsies in the lung, providing a less invasive alternative for patients.

In addition to its innovative products, the company offers a comprehensive suite of instrumentation, including stapling, energy, and core instruments, designed to work seamlessly with its multi-port da Vinci surgical systems.

Intuitive Surgical is committed to supporting its customers throughout their journey, providing progressive learning pathways, expert-led training, and a dedicated team of service and support specialists to ensure optimal system performance and maintenance.

The company's integrated digital capabilities provide hospitals with actionable insights, streamlining performance and enhancing program outcomes. With a strong focus on customer success, Intuitive Surgical sells its products through a direct sales organization, comprising capital and clinical sales teams.

Through strategic collaborations, such as its agreement with FluoGuide A/S for head and neck cancer, Intuitive Surgical continues to push the boundaries of medical innovation, improving patient outcomes and shaping the future of healthcare.

Founded in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical is a leader in the medical technology industry, committed to advancing the art of minimally invasive care. Learn more at https://www.intuitive.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for ISRG - Intuitive Surgical  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for ISRG - Intuitive Surgical  - Stock Price & Dividends

ISRG Stock Overview

Market Cap in USD 156,886m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 2000-06-13

ISRG Stock Ratings

Growth 5y 68.8
Fundamental 52.7
Dividend -
Rel. Performance vs Sector 1.48
Analysts 4.10/5
Fair Price Momentum 443.84 USD
Fair Price DCF 22.28 USD

ISRG Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

ISRG Growth Ratios

Growth 12m 25.47%
Growth Correlation 12m 65%
Growth Correlation 3m 85%
CAGR 5y 20.30%
CAGR/Mean DD 5y 1.48
Sharpe Ratio 12m 0.75
Alpha vs SP500 12m -11.43
Beta vs SP500 5y weekly 1.50
ValueRay RSI 62.83
Volatility GJR Garch 1y 19.62%
Price / SMA 50 7.23%
Price / SMA 200 23.27%
Current Volume 1151.6k
Average Volume 20d 1475.5k

External Links for ISRG Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of ISRG stocks?
As of July 14, 2024, the stock is trading at USD 444.16 with a total of 1,151,601 shares traded.
Over the past week, the price has changed by +0.09%, over one month by +3.75%, over three months by +15.43% and over the past year by +25.53%.
What are the forecast for ISRG stock price target?
According to ValueRays Forecast Model, ISRG Intuitive Surgical will be worth about 499.8 in July 2025. The stock is currently trading at 444.16. This means that the stock has a potential upside of +12.53%.
Issuer Forecast Upside
Wallstreet Target Price 431.9 -2.76
Analysts Target Price 332.8 -25.1
ValueRay Target Price 499.8 12.5

Intuitive Surgical Inc - Pioneering Robotic-Assisted Surgery

History Unveiled

Founded in 1995, Intuitive Surgical Inc has blazed a trail in the field of medical technology by introducing robotic-assisted surgery to healthcare. Their flagship creation, the da Vinci Surgical System, revolutionized surgical procedures, making them less invasive, and thus, reducing recovery times for patients. The idea was not just revolutionary but also filled with immense potential, spearheading a new era in surgical precision and patient care.

The Core of Intuitive Surgical

At its core, Intuitive Surgical is dedicated to improving patient outcomes through its advanced robotic-assisted surgical systems. The da Vinci system, its star innovation, allows surgeons to perform complex surgeries with enhanced vision, precision, and control. This core technology has positioned Intuitive Surgical as a leader in the domain of minimally invasive surgery, continuously pushing the boundaries of what's possible in operating rooms around the world.

Beyond the Operating Room

Besides its primary focus, Intuitive Surgical has expanded its prowess into a range of complementary businesses. This includes developing innovative imaging and energy products designed to further enhance surgical precision. The company has also invested in training programs and simulation products to ensure surgeons can fully leverage the capabilities of the da Vinci system. This holistic approach ensures not just technological advancement but also the practical application and continuous improvement of surgical skills globally.

Current Market Status

As of now, Intuitive Surgical continues to hold a strong position in the market. With the da Vinci systems being used in thousands of hospitals around the world, the company has a deeply entrenched market presence. Continuous innovation, alongside a growing acceptance of robotic-assisted surgery across diverse medical fields, has kept Intuitive Surgical in a leading position. The landscape is competitive, with emerging technologies and players, but Intuitive Surgical's pioneering advantage, sustained research and development, and comprehensive support services keep it at the forefront of the industry.